Tronox Reports Massive $473M Net Loss for 2025, Leverage Soars to 9.0x Amid Plant Closures & Credit Downgrades
Summary
Tronox Holdings plc reported a $473 million net loss for 2025, a significant increase from the prior year, with net debt to Adjusted EBITDA soaring to 9.0x, reflecting severe financial deterioration and increased leverage.
Key Events
-
Financial Performance Collapse
Reported a net loss of $473 million for 2025, a sharp decline from a $54 million loss in 2024, driven by a 6% decrease in net sales and a 7.5 percentage point drop in gross margin. Adjusted EBITDA fell significantly from $564 million to $336 million.
-
Soaring Leverage & Credit Downgrades
Net debt to trailing-twelve month Adjusted EBITDA surged to an alarming 9.0x in 2025 from 4.8x in 2024. Both Moody's and S&P Global Ratings downgraded the company's credit ratings to B2 negative and CCC+ negative, respectively.
-
Major Restructuring Charges
Incurred $232 million in restructuring and other charges in 2025 related to the indefinite idling of its Botlek plant in the Netherlands and the permanent closure of its Fuzhou, China TiO2 pigment plant.
-
Dividend Cut & Capital Raise
Reduced its quarterly dividend by 60% effective Q3 2025. Successfully closed a $400 million offering of 9.125% senior secured notes due 2030 in September 2025, providing liquidity but at a high interest rate.
Analysis
The 2025 annual report reveals a severe deterioration in Tronox's financial health, with a substantial net loss and a dramatic increase in leverage. This comprehensive filing confirms the challenging market conditions and strategic actions previously hinted at, including significant restructuring charges from plant closures and a dividend reduction. The credit rating downgrades further underscore the heightened financial risk. Investors should be aware of the company's precarious financial position and the ongoing legal challenges.
At the time of this filing, TROX was trading at $6.81 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.86 to $8.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.